United StatesAripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, marketed by Ajanta Pharma USA Inc (NDC 27241-056-03), Lot PA00805, expiration 01/31/2029 — 6,143 bottles distributed nationwide are affected. They were recalled because bottles containing Voriconazole Tablets 50 mg were labeled and distributed as Aripiprazole Tablets 30 mg.
What's being recalled
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Recalling firm: Ajanta Pharma USA Inc, Bridgewater, NJ, United States.
How to identify it
Lot: PA00805, expires: 01/31/2029
The hazard
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)